Inmune Bio (INMB) EPS (Diluted) (2021 - 2026)
Powered by 
Analysis
Inmune Bio (INMB) EPS (Diluted) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 1.79 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | -1.18 |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 0.05 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 0.04 |
| 10 | Inmune Bio | 67.48 Mn | 49.06 Mn | - | -0.06 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.06 |
| Mar 31, 2026 | -0.22 |
| Dec 31, 2025 | -0.22 |
| Sep 30, 2025 | -0.28 |
| Jun 30, 2025 | -1.05 |
| Mar 31, 2025 | -0.44 |
| Dec 31, 2024 | -0.47 |
| Sep 30, 2024 | -0.61 |
| Jun 30, 2024 | -0.51 |
| Mar 31, 2024 | -0.61 |
| Dec 31, 2023 | -0.47 |
| Sep 30, 2023 | -0.48 |
| Jun 30, 2023 | -0.36 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.33 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.38 |
| Mar 31, 2022 | -0.39 |
| Dec 31, 2021 | -0.60 |
| Sep 30, 2021 | -0.55 |